Acute Myelomonocytic Leukemia - 7 Studies Found
Active, not recruiting |
: Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia :
|
Active, not recruiting |
: Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia :
|
Active, not recruiting |
: Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia :
: |
Completed |
: Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
: |
Active, not recruiting |
: Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers :
|
Completed |
: Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia :
|
Completed |
: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases :
|